Open original FDA record ↗Recall record
- FDA identifier
- Z-1618-2023
- Company in FDA record
- BERLIN HEART GMBH
- FDA classification date
- May 25, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
There is a potential for a disruption in one or more of the triple layer membranes of the ventricular assist device. Recall occurred in 2018, and was retrospectively reported.
Source facts
- Action
- On May 18, 2018, Berlin Heart issued a Safety Communication via E-Mail to affected consignee. The Safety Communication asked consignees to take the following actions: 1. Always follow the information and instructions provided in the Instructions for Use that have been provided to you by Berlin Heart. Information related to the specific issues discussed within the letter is included in Chapter 12 starting on page 115, specifically Section 12.5, and 12.51. 2. Additional information on troubleshooting is found in Chapter 16 starting on page 161. 3. If you have any questions or concerns regarding the communication, please contact Clinical Affairs team directly at 281-863-9700
- Initiated
- 2018-05-18
- Root cause
- Component design/selection
- Terminated
- 2024-06-06
- Distribution
- Distribution to US states of MA, TX, WI, CA, SC, FL, CO, NY, PA, NC, UT, GA, MN, OH, AZ, AL, and Canada
- Recall number
- Z-1618-2023
- Recall status
- Terminated
- CDRH record ID
- 199758
- FDA classified
- 2023-05-25
- Recall event number
- 92132